Dave Furneaux

Founder & CEO, BlueIO

📍 Greater Boston, United States🔄 Updated September 2026💼 20 investments📅 31 years investing🗓 Last invested Jun 2014
Operator-angel🌍 United States20+ investments
20
Total investments
7
Early stage
0
Mid stage
1
Late stage
31y
Years active

Portfolio

10 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Co-founder, First investor, Vice Chair of the Board
Jun 2014
Virsec is a zero trust protection platform for application workloads. Radically strengthen your security program, stop attacks in milliseconds, and eliminate dwell time with Virsec’s precise, continuous workload protection.
Investor
2013
MagnaCom is a recognized technology innovation powerhouse aiming to reinvent the evolution of digital communications. The company was founded around a whole new, patented modulation technology called WAM, which can help alleviate the global spectrum congestion and insatiable demand for more bandwidth. This impacts nearly all forms of modern communications – including cellular, Wi-Fi, satellite and cable TV, wireless backhaul, cable modems and numerous other applications. WAM technology applies to carriers, handset manufacturers, wired and wireless system OEMs, and communication IC vendors who strive to save spectrum, increase bandwidth, speed and distance, or reduce power consumption. With over 40 issued patents and over 70 more pending MagnaCom is challenging the 40-year dominance of QAM as the modulation of choice for all advanced wired and wireless systems. Contact us at info@magna-com.com
Investor
2012
WhoKnows has build a B2B lead gen platform for startups with AI-enriched prospect data (370M prospects), a growth lab with rapid omni-channel campaign testing (email, paid ads, SDRs, SEO, etc), agile marketing services , and startup-friendly pricing. It’s the fastest, most affordable way to discover and scale your optimal lead gen engine.
Founding investor, Board member
2010
GreenLight Biosciences is a mission-driven public-benefit corporation using the power of RNA to tackle some of humanitys greatest challenges, including pandemics, rare diseases, biodiversity and climate change.
early stageBiotechnology
Founding investor, Board member
2009
Lumicell is a privately held company focused on innovative fluorescence-guided technologies for cancer surgery with the potential to improve patient outcomes and reduce healthcare costs. The company’s first product is the Lumicell Direct Visualization System, designed to provide real-time illumination of cancerous tissue within the breast cavity during the initial lumpectomy, potentially reducing repeat surgeries. Lumicell’s proprietary, pan-oncologic optical imaging agent is also being explored across a wide variety of solid tumor indications. The company aims to enhance the standard of care treatment by guiding the resection of additional cancer that may have otherwise been left behind.
Investor
2007
As a society we’ve always dreamt of a healthy, disease-free world. One of the bravest moves in that direction has come from stem cell research and therapy. Stem cell therapy is currently being used to successfully treat more than 80 diseases, but we think there’s still a long way to go. Smart Cells is the first private UK stem cell storage company to have released stored stem cell units for use in the treatment of children with life-threatening illnesses. We have released the greatest number of samples for use in successful transplants in the UK. We believe with the development of technology in the future we will be able to treat even more illnesses, and we’re working on it. We believe our customers deserve the best service available and we staff our state of the art facility with the top professionals in the field. We believe that storing your child’s stem cells at birth can be a crucial part of curing an unexpected illness. We believe that in the future this service should be available to every parent, child and family. We are a company that is for life.
late stageBiotechnology
Founding investor, Board member
Jun 2000
Juniper Networks has acquired BTI Systems. The combined innovations of these two companies means that our users gain a comprehensive, end-to-end product portfolio to address the fast- growing markets for data center interconnect and metro packet optical transport.
Formation investor, Board member
1998
Formation investor, Board member
1996
InterSense Incorporated is a market leader in precision motion technology. Its patented Hybrid Technology tracks motion with an unmatched combination of real-time positioning, tracking and alignment capabilities, bringing higher speed and quality to visual simulation, enhanced vision and navigation applications. InterSense’s premier motion tracking products enable real-time, realistic interaction with computer graphics to enhance technical applications in training and simulation, robotics, augmented reality, 3D virtual displays, video/film/game development and production, oil and gas exploration, and medical imaging. In addition to a marquis global customer base spanning the military, industrial, entertainment, research, engineering and life sciences industries, InterSense also works with a network of software solution partners, systems integrators, value added resellers and OEM hardware partners.
Experience · 25 entries
All (25)
Investments (17)
Founder (8)
Board (7)
2015
Co-Founder & Chairman, Investor
Mar 2015
At Causemo, we believe fundraising should be easier and more efficient for nonprofits. Our single platform solution powers multi-channel campaigns using big data and machine learning. We fuse information about your donors with our extensive set of third party philanthropic giving data to create enriched profiles and uncover new opportunities to engage with more of your best prospects inside and outside of your known donor base. Nonprofits using Causemo see a lower cost per donor acquisition, higher conversion to second action and are fully supported from creative to execution by our team of data and fundraising experts.
2014
Co-founder, First investor, Vice Chair of the Board
Jun 2014
Virsec is a zero trust protection platform for application workloads. Radically strengthen your security program, stop attacks in milliseconds, and eliminate dwell time with Virsec’s precise, continuous workload protection.
Clearwater Clinical Limited (Acquired by EQT Partners)
Investor
2014
2013
Investor
2013
MagnaCom is a recognized technology innovation powerhouse aiming to reinvent the evolution of digital communications. The company was founded around a whole new, patented modulation technology called WAM, which can help alleviate the global spectrum congestion and insatiable demand for more bandwidth. This impacts nearly all forms of modern communications – including cellular, Wi-Fi, satellite and cable TV, wireless backhaul, cable modems and numerous other applications. WAM technology applies to carriers, handset manufacturers, wired and wireless system OEMs, and communication IC vendors who strive to save spectrum, increase bandwidth, speed and distance, or reduce power consumption. With over 40 issued patents and over 70 more pending MagnaCom is challenging the 40-year dominance of QAM as the modulation of choice for all advanced wired and wireless systems. Contact us at info@magna-com.com
2012
BlueIO
Founder, Chairman & CEO
Jun 2012
Show all 25 entries ↓
Investment activity
1995–2014 · 20 investments
199511996119971199822000120012200412006120071200912010320111201212013120142
Recent (last 2 years)Earlier